Medico Intercontinental Q3FY26 Results Show Growth

Medico Intercontinental reported Q3FY26 revenue of ₹1275.12 lakhs vs ₹1142.82 lakhs YoY, with net profit rising to ₹61.15 lakhs from ₹54.66 lakhs in Q3FY25.

Medico Intercontinental Promoter Increases Stake to 46.40%

Managing Director Samir Shah acquired 1,97,285 shares via open market purchase, increasing his holding from 44.83% to 46.40% under SEBI substantial acquisition regulations.

Medico Intercontinental Reports Strong Growth with 345% Revenue Jump in Q1 Results

Medico Intercontinental Limited, an Ahmedabad-based pharmaceutical company, reported significant growth in its quarterly results. On a standalone basis, total income from operations increased 345% to Rs. 3,011.32 lakhs compared to Rs. 676.44 lakhs in the same quarter last year. Net profit after tax rose to Rs. 483.50 lakhs from Rs. 44.42 lakhs, while earnings per share grew to Rs. 3.19 from Rs. 0.37. On a consolidated basis, total income increased 263% to Rs. 3,330.41 lakhs from Rs. 916.11 lakhs, with net profit after tax rising to Rs. 566.84 lakhs from Rs. 152.27 lakhs. Consolidated EPS improved to Rs. 3.90 from Rs. 1.27. The Board of Directors approved these unaudited financial results on August 14, 2025.